Increased flow-mediated vasodilation in cirrhotic patients with ascites: Relationship with renal resistive index

Massimo Cazzaniga, Francesco Salerno, Stefania Visentin, Ilaria Cirello, Cesare Donarini, Massimo Cugno

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Background: Peripheral vasodilation is the key factor in the development of hyperdynamic circulation, sodium retention and functional renal failure in patients with cirrhosis. Brachial artery flow-mediated dilation (FMD) after transient vascular occlusion is a non-invasive method to assess the shear stress-induced arterial vasodilation. Aims: To evaluate FMD in cirrhotic patients with and without ascites and to assess the relationship between FMD and intrarenal resistances. Methods: Flow-mediated dilation was determined in 32 cirrhotic patients (22 with ascites) and 12 healthy controls and correlated with the intrarenal resistive index (RI) assessed by Doppler exploration. Results: Basal diameter of the brachial artery was similar in healthy controls and in cirrhotic patients, whereas FMD was significantly higher in patients with cirrhosis and ascites [29.5% (range 10.3-50%)] than in pre-ascitic patients [17.3% (range 2.4-48.5%)] and healthy control subjects [11.6% (range 5.1-17.8%)] (P <0.001). Intrarenal RI was significantly higher in patients with cirrhosis than in healthy subjects, and a direct relationship existed between FMD and intrarenal RI (r = 0.66; P <0.00001). Conclusions: These findings in vivo demonstrate that cirrhotic patients with ascites have an enhanced shear stress-induced peripheral vasodilation, which is closely related to intrarenal vasoconstriction.

Original languageEnglish
Pages (from-to)1396-1401
Number of pages6
JournalLiver International
Volume28
Issue number10
DOIs
Publication statusPublished - 2008

Fingerprint

Ascites
Vasodilation
Kidney
Dilatation
Fibrosis
Brachial Artery
Healthy Volunteers
Vasoconstriction
Renal Insufficiency
Blood Vessels
Sodium

Keywords

  • Ascites
  • Cirrhosis
  • Kidney
  • Nitric oxide
  • Peripheral vasodilation

ASJC Scopus subject areas

  • Hepatology

Cite this

Increased flow-mediated vasodilation in cirrhotic patients with ascites : Relationship with renal resistive index. / Cazzaniga, Massimo; Salerno, Francesco; Visentin, Stefania; Cirello, Ilaria; Donarini, Cesare; Cugno, Massimo.

In: Liver International, Vol. 28, No. 10, 2008, p. 1396-1401.

Research output: Contribution to journalArticle

Cazzaniga, Massimo ; Salerno, Francesco ; Visentin, Stefania ; Cirello, Ilaria ; Donarini, Cesare ; Cugno, Massimo. / Increased flow-mediated vasodilation in cirrhotic patients with ascites : Relationship with renal resistive index. In: Liver International. 2008 ; Vol. 28, No. 10. pp. 1396-1401.
@article{b2fad508a5ca456b9d6bea7c6021f9d7,
title = "Increased flow-mediated vasodilation in cirrhotic patients with ascites: Relationship with renal resistive index",
abstract = "Background: Peripheral vasodilation is the key factor in the development of hyperdynamic circulation, sodium retention and functional renal failure in patients with cirrhosis. Brachial artery flow-mediated dilation (FMD) after transient vascular occlusion is a non-invasive method to assess the shear stress-induced arterial vasodilation. Aims: To evaluate FMD in cirrhotic patients with and without ascites and to assess the relationship between FMD and intrarenal resistances. Methods: Flow-mediated dilation was determined in 32 cirrhotic patients (22 with ascites) and 12 healthy controls and correlated with the intrarenal resistive index (RI) assessed by Doppler exploration. Results: Basal diameter of the brachial artery was similar in healthy controls and in cirrhotic patients, whereas FMD was significantly higher in patients with cirrhosis and ascites [29.5{\%} (range 10.3-50{\%})] than in pre-ascitic patients [17.3{\%} (range 2.4-48.5{\%})] and healthy control subjects [11.6{\%} (range 5.1-17.8{\%})] (P <0.001). Intrarenal RI was significantly higher in patients with cirrhosis than in healthy subjects, and a direct relationship existed between FMD and intrarenal RI (r = 0.66; P <0.00001). Conclusions: These findings in vivo demonstrate that cirrhotic patients with ascites have an enhanced shear stress-induced peripheral vasodilation, which is closely related to intrarenal vasoconstriction.",
keywords = "Ascites, Cirrhosis, Kidney, Nitric oxide, Peripheral vasodilation",
author = "Massimo Cazzaniga and Francesco Salerno and Stefania Visentin and Ilaria Cirello and Cesare Donarini and Massimo Cugno",
year = "2008",
doi = "10.1111/j.1478-3231.2008.01847.x",
language = "English",
volume = "28",
pages = "1396--1401",
journal = "Liver International",
issn = "1478-3223",
publisher = "Wiley-Blackwell Publishing Ltd",
number = "10",

}

TY - JOUR

T1 - Increased flow-mediated vasodilation in cirrhotic patients with ascites

T2 - Relationship with renal resistive index

AU - Cazzaniga, Massimo

AU - Salerno, Francesco

AU - Visentin, Stefania

AU - Cirello, Ilaria

AU - Donarini, Cesare

AU - Cugno, Massimo

PY - 2008

Y1 - 2008

N2 - Background: Peripheral vasodilation is the key factor in the development of hyperdynamic circulation, sodium retention and functional renal failure in patients with cirrhosis. Brachial artery flow-mediated dilation (FMD) after transient vascular occlusion is a non-invasive method to assess the shear stress-induced arterial vasodilation. Aims: To evaluate FMD in cirrhotic patients with and without ascites and to assess the relationship between FMD and intrarenal resistances. Methods: Flow-mediated dilation was determined in 32 cirrhotic patients (22 with ascites) and 12 healthy controls and correlated with the intrarenal resistive index (RI) assessed by Doppler exploration. Results: Basal diameter of the brachial artery was similar in healthy controls and in cirrhotic patients, whereas FMD was significantly higher in patients with cirrhosis and ascites [29.5% (range 10.3-50%)] than in pre-ascitic patients [17.3% (range 2.4-48.5%)] and healthy control subjects [11.6% (range 5.1-17.8%)] (P <0.001). Intrarenal RI was significantly higher in patients with cirrhosis than in healthy subjects, and a direct relationship existed between FMD and intrarenal RI (r = 0.66; P <0.00001). Conclusions: These findings in vivo demonstrate that cirrhotic patients with ascites have an enhanced shear stress-induced peripheral vasodilation, which is closely related to intrarenal vasoconstriction.

AB - Background: Peripheral vasodilation is the key factor in the development of hyperdynamic circulation, sodium retention and functional renal failure in patients with cirrhosis. Brachial artery flow-mediated dilation (FMD) after transient vascular occlusion is a non-invasive method to assess the shear stress-induced arterial vasodilation. Aims: To evaluate FMD in cirrhotic patients with and without ascites and to assess the relationship between FMD and intrarenal resistances. Methods: Flow-mediated dilation was determined in 32 cirrhotic patients (22 with ascites) and 12 healthy controls and correlated with the intrarenal resistive index (RI) assessed by Doppler exploration. Results: Basal diameter of the brachial artery was similar in healthy controls and in cirrhotic patients, whereas FMD was significantly higher in patients with cirrhosis and ascites [29.5% (range 10.3-50%)] than in pre-ascitic patients [17.3% (range 2.4-48.5%)] and healthy control subjects [11.6% (range 5.1-17.8%)] (P <0.001). Intrarenal RI was significantly higher in patients with cirrhosis than in healthy subjects, and a direct relationship existed between FMD and intrarenal RI (r = 0.66; P <0.00001). Conclusions: These findings in vivo demonstrate that cirrhotic patients with ascites have an enhanced shear stress-induced peripheral vasodilation, which is closely related to intrarenal vasoconstriction.

KW - Ascites

KW - Cirrhosis

KW - Kidney

KW - Nitric oxide

KW - Peripheral vasodilation

UR - http://www.scopus.com/inward/record.url?scp=54049132530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=54049132530&partnerID=8YFLogxK

U2 - 10.1111/j.1478-3231.2008.01847.x

DO - 10.1111/j.1478-3231.2008.01847.x

M3 - Article

C2 - 18673435

AN - SCOPUS:54049132530

VL - 28

SP - 1396

EP - 1401

JO - Liver International

JF - Liver International

SN - 1478-3223

IS - 10

ER -